Bdr Pharmaceuticals International Profile
Key Indicators
- Authorised Capital ₹ 1.12 Cr
as on 17-11-2024
- Paid Up Capital ₹ 5.40 M
as on 17-11-2024
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.00 Cr
as on 17-11-2024
- Revenue -35.19%
(FY 2023)
- Profit -46.45%
(FY 2023)
- Ebitda -56.90%
(FY 2023)
- Net Worth 38.60%
(FY 2023)
- Total Assets 31.16%
(FY 2023)
About Bdr Pharmaceuticals International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.12 Cr and a paid-up capital of Rs 5.40 M.
The company has closed loans amounting to ₹9.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bdr Pharmaceuticals International Private Limited India are Anand Bagaria as CFO and Pinky Shah as Company Secretary. Manish Gaur, Dharmesh Shah, Tejash Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PTC137329
- Company No.
137329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2002
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bdr Pharmaceuticals International?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Bagaria | CFO | Current | |
Pinky Shah  | Company Secretary | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejash Shah | Director | 16-Jan-2008 | Current |
| Raheel Shah | Director | 27-Jul-2011 | Current |
| Manish Gaur | Nominee Director | 12-May-2022 | Current |
| Dharmesh Shah | Director | 13-May-2022 | Current |
| Aravind Badiger | Director | 15-Dec-2012 | Current |
| Jayesh Trivedi | Director | 04-Dec-2020 | Current |
Financial Performance of Bdr Pharmaceuticals International.
Bdr Pharmaceuticals International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.19% decrease. The company also saw a substantial fall in profitability, with a 46.45% decrease in profit. The company's net worth Soared by an impressive increase of 38.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bdr Pharmaceuticals International?
In 2023, Bdr Pharmaceuticals International had a promoter holding of 93.01% and a public holding of 6.99%. The company had 4 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spinos Life Science And Research Private LimitedActive 8 years 8 monthsRaheel Shah and Aravind Badiger are mutual person
Bdr Lifesciences Private LimitedActive 31 years 2 monthsTejash Shah and Raheel Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Abn Amro Bank N. V. Creation Date: 15 Mar 2006 | ₹9.00 Cr | Satisfied |
How Many Employees Work at Bdr Pharmaceuticals International?
Unlock and access historical data on people associated with Bdr Pharmaceuticals International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bdr Pharmaceuticals International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bdr Pharmaceuticals International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
